EA199800146A1 - Использование иприфлавона для понижения числа cd8+ клеток - Google Patents

Использование иприфлавона для понижения числа cd8+ клеток

Info

Publication number
EA199800146A1
EA199800146A1 EA199800146A EA199800146A EA199800146A1 EA 199800146 A1 EA199800146 A1 EA 199800146A1 EA 199800146 A EA199800146 A EA 199800146A EA 199800146 A EA199800146 A EA 199800146A EA 199800146 A1 EA199800146 A1 EA 199800146A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
ippriflavon
reduce
cell number
isoflavone
Prior art date
Application number
EA199800146A
Other languages
English (en)
Russian (ru)
Inventor
Аттила Б.Ковач
Петер Араньи
Терезия Керепеши
Дьёрдь Вараи
Аттила Тар
Original Assignee
Чиноин Дьёдьсер Еш Ведьесети Термекек Дьяра Рт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чиноин Дьёдьсер Еш Ведьесети Термекек Дьяра Рт filed Critical Чиноин Дьёдьсер Еш Ведьесети Термекек Дьяра Рт
Publication of EA199800146A1 publication Critical patent/EA199800146A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
EA199800146A 1995-07-21 1996-07-16 Использование иприфлавона для понижения числа cd8+ клеток EA199800146A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
EA199800146A1 true EA199800146A1 (ru) 1998-08-27

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800146A EA199800146A1 (ru) 1995-07-21 1996-07-16 Использование иприфлавона для понижения числа cd8+ клеток

Country Status (22)

Country Link
EP (1) EP0841915A1 (de)
JP (1) JP2001503371A (de)
KR (1) KR19990028933A (de)
CN (1) CN1191483A (de)
AR (1) AR002905A1 (de)
AU (1) AU6367096A (de)
BG (1) BG102182A (de)
BR (1) BR9610187A (de)
CA (1) CA2227421A1 (de)
CZ (1) CZ2798A3 (de)
EA (1) EA199800146A1 (de)
EE (1) EE9800020A (de)
HR (1) HRP960345A2 (de)
HU (1) HU9502198D0 (de)
IL (1) IL122751A0 (de)
MX (1) MX9800603A (de)
NO (1) NO980127L (de)
PL (1) PL324460A1 (de)
SK (1) SK3298A3 (de)
WO (1) WO1997003664A1 (de)
YU (1) YU42796A (de)
ZA (1) ZA966079B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
HRP960345A2 (en) 1998-02-28
IL122751A0 (en) 1998-08-16
EE9800020A (et) 1998-08-17
BG102182A (en) 1998-08-31
NO980127D0 (no) 1998-01-12
EP0841915A1 (de) 1998-05-20
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
CZ2798A3 (cs) 1998-06-17
MX9800603A (es) 1998-04-30
KR19990028933A (ko) 1999-04-15
AR002905A1 (es) 1998-04-29
SK3298A3 (en) 1998-07-08
JP2001503371A (ja) 2001-03-13
NO980127L (no) 1998-01-12
CN1191483A (zh) 1998-08-26
YU42796A (sh) 1999-03-04
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
AU6367096A (en) 1997-02-18
CA2227421A1 (en) 1997-02-06
ZA966079B (en) 1998-01-19
BR9610187A (pt) 1998-07-28

Similar Documents

Publication Publication Date Title
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
EA200100103A1 (ru) Ингибиторы адгезии клеток
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
IL74535A (en) Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof
DK0735890T3 (da) Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning
KR900018098A (ko) 피리돈 카르복실산과 항균제
TW282393B (de)
ZA83628B (en) Pharmacologically active pyrazolo/4,3-/pyridines
DE3862337D1 (de) Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten.
CA2195419A1 (en) Immunological activity of rhamnolipids
GB2075341B (en) Pharmaceutical compositions
EA199900876A1 (ru) Фармацевтические композиции против кашля
IE861623L (en) Biologically active copolymer composition
GB2114886B (en) Skin treatment compositions containing biotin antagonists
MD1688F2 (en) Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
BG78461A (bg) Фунгициден състав и метод за борба с фунги
BE887566A (fr) Nouveaux acides 2-amino-3-(alpha-hedroxybenzyl)-phenylacetiques et leur esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
EA199800146A1 (ru) Использование иприфлавона для понижения числа cd8+ клеток
CA2016470A1 (en) Pharmaceutical preparation and method of treatment for liver dysfunction
KR850700108A (ko) 항종양 의약 조성물 및 그의 제조 방법
ES8406468A1 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
Andrade et al. Comparative study of the action of purified scorpion toxin (tityustoxin) on the submandibular and parotid glands of the rat